Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China.

MLA

Huang, Tao, et al. “Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China.” Frontiers in Pharmacology, vol. 13, Feb. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fphar.2022.757398.

APA

Huang, T., Bai, L., Wushouer, H., Wang, Z., Yang, M., Lin, H., Shen, P., Guan, X., & Shi, L. (2022). Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China. Frontiers in Pharmacology, 13, 1–9. https://doi.org/10.3389/fphar.2022.757398

Chicago

Huang, Tao, Lin Bai, Haishaerjiang Wushouer, Zhiyuan Wang, Mingchun Yang, Hongbo Lin, Peng Shen, Xiaodong Guan, and Luwen Shi. 2022. “Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China.” Frontiers in Pharmacology 13 (February): 1–9. doi:10.3389/fphar.2022.757398.